Injective (INJ) is currently priced at $3.44, reflecting a 3.77% increase over the last 24 hours. The asset has shown a daily trading range of $3.31 to $3.50, indicating healthy volatility and investor interest.

The volume over the past 24 hours is approximately $69.55 million, representing 20.26% of its market capitalization, which suggests robust liquidity. Short-term moving averages are showing bullish signals, with the 8 SMA at $3.44 indicating a slight upward trend, while longer-term averages like the 55 SMA at $3.35 show more significant gains of 2.72%.

The 1-hour RSI stands at 59, suggesting that INJ is approaching overbought territory, while the 7-day RSI at 54 indicates more balanced momentum. Over the past two weeks, the price has increased by 12.91%, reflecting strong bullish sentiment, while the 30-day price change of 11.40% further underscores the asset's positive performance.

Despite a significant gap from its all-time high of $52.62, reached on March 14, 2024, the current price level shows potential for recovery and further gains. The consistent upward movement in various timeframes suggests an overall positive trend, supported by increasing volumes and a solid market presence.

Given the current indicators, particularly the short-term bullish moving averages and the healthy RSI levels, a Buy rating is warranted. The asset is positioned well for potential short-term gains, especially if it can maintain momentum above the key support levels established at $3.31.